CTMX — CytomX Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for CytomX Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K/A	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	316	305	194	175	101
Net Total Accounts Receivable
Net Total Receivables	0.798	0.79	36	3.43	3.1
Prepaid Expenses
Total Current Assets	324	310	237	183	107
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	29.4	25.3	21	16.2	10.6
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	359	339	261	202	121
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	101	77.9	153	156	85.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	309	340	347	249	121
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	49.8	-0.459	-85.8	-47.4	-0.456
Total Liabilities & Shareholders' Equity	359	339	261	202	121
Total Common Shares Outstanding